Industry groups call for better alignment between decentralized, centralized trials
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development